Lemus David has filed 4 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 90000 shares of Silence Therapeutics plc ($SLN) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Silence Therapeutics plc | $SLN | Lemus David | Not found | A | Share Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 141,701,848 | 9999.99% | 0.06% |
| Jan. 2, 2025 | Silence Therapeutics plc | $SLN | Lemus David | Not found | A | Share Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 138,752,224 | 9999.99% | 0.03% |
| Oct. 17, 2024 | Scilex Holding Co | $SCLX | Lemus David | Not found | P | Common Stock | 2000 | $0.90 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | Scilex Holding Co | $SCLX | Lemus David | Not found | A | Nonstatutory Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |